FDA, COVID-19 and vaccine
Digest more
Top News
Overview
Impacts
The Food and Drug Administration announced Tuesday it is adopting a new regulatory framework for COVID-19 vaccines that will likely narrow recommendations for the vaccines to people over 65 and those at high risk for severe outcomes—a switch that could ...
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are healthy
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
President Donald Trump’s administration is slated to lay out its approach to Covid vaccination at an event Tuesday that could spell major changes in what is required to get regulatory approval for immunizations.
FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.”
Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two related deaths, according to the FDA and CDC.